Yawan kararrakin COVID-19 a China, Amurka da Japan, musamman a China, sun yi kararrawa a duk duniya ciki har da Indiya. Ya haifar da tambaya kan dogaro da yawa kan zato na 'cikakkiyar tasiri' na nasarar rigakafin da aka yi a Indiya da galibin ƙasashe na duniya.
Ko da yake, ba a san ainihin yanayin kwayar cutar ba (a cikin sharuddan kwayoyin halitta) da ke da alhakin halin da ake ciki yanzu a kasar Sin ba kuma ba a san ainihin adadin mace-mace da asibitoci ba, amma rahotannin da ke fitowa suna nuna mummunan hoto da ka iya yin tasiri ga sauran kasashen duniya. .
An yi hasashen cewa, halin da ake ciki na yanzu zai iya zama na farko a cikin raƙuman hunturu guda uku, wanda ke da alaƙa da balaguron balaguro kafin da kuma bayan bikin sabuwar shekara ta Sinawa a ranar 22 ga Janairu 2023 (wani yanayin da ke tunawa da farkon lokacin cutar ta COVID-19 da aka gani a shekarar 2019) 2020).
Babban shirin rigakafin COVID-19 a China ya ga kusan kashi 92% na mutane suna karɓar aƙalla kashi ɗaya. Adadin mutanen da ke da shekaru 80+ (waɗanda suka fi rauni), duk da haka, ba shi da gamsarwa a 77% (an karɓi aƙalla kashi ɗaya), 66% (an karɓi 2).nd kashi), da kuma 41% (an karɓi kashi na ƙarfafawa kuma).
Wani abu kuma shine nau'in rigakafin da ake amfani da shi don rigakafi a China - Sinovac (kuma aka sani da CoronaVac) wanda, kamar Covaxin na Indiya, ƙwayar cuta ce gabaɗaya wacce ba a kunna ba ta COVID-19.
Sifa ta uku a bayan yanayin halin da ake ciki yanzu a cikin lamura a China shine tsauraran manufofin su na COVID-COVID wanda ya hana mutane -mu'amala da mutane wanda ya iyakance adadin kwayar cutar kuma ya sami nasarar kiyaye adadin masu mutuwa zuwa mafi ƙasƙanci (idan aka kwatanta da Mummunan asarar rayuka a Indiya yayin tashin hankali na biyu) amma, a lokaci guda, hulɗar kusa-sifili shima bai dace ba don haɓaka rigakafin garken garken garken dabbobi a cikin yawan jama'a kuma an bar mutane kawai akan allurar rigakafin da ke haifar da rigakafi mai aiki wanda wataƙila ya kasance ko kaɗan. tasiri a kan kowane sabon bambance-bambancen da/ko, rigakafin da aka jawo ya lalace a kan lokaci.
A gefe guda, a Indiya, ta hanyar dimokiradiyya (!), ba za a iya aiwatar da nisantar da jama'a da manufofin keɓancewa ba wanda za a iya cewa yana ɗaya daga cikin mahimman dalilan da ke haifar da adadin mace-mace yayin tashin hankali na biyu. Amma, wasu mu'amala tsakanin mutane da mutane, a lokacin, sun kuma taimaka wajen samar da aƙalla matakin rigakafin garken garken jama'a. Hakanan za'a iya bayar da hujjar cewa matsi na zaɓi mara kyau ya yi aiki akan waɗanda ke da ƙayyadaddun kwayoyin halitta kuma an kawar da su. Don haka, wanda zai iya ƙara jayayya cewa yawan jama'ar Indiya a yanzu, yana da nau'in rigakafi na matasan (haɗin maganin rigakafi da ke haifar da rigakafi mai aiki da rigakafi na garken jama'a).
Har ila yau, a Indiya, an yi amfani da nau'o'in nau'o'in alluran rigakafi - ƙwayoyin cuta marasa aiki (Covaxin) da DNA recombinant a cikin adenovirus vector (Covishield).
Idan halin da ake ciki yanzu a kasar Sin ya samo asali ne daga juyin halitta da kuma yada wani sabon bambance-bambancen sabon coronavirus wanda ke da kamuwa da cuta mai yawa da cutar za a san shi ne kawai da zarar an kammala jerin kwayoyin halitta kuma aka buga. Idan lamarin ya tabbata ga wani sabon bambance-bambance a kan wanda allurar rigakafi na yanzu ba su da tasiri, to hakan zai buƙaci gudanar da taro mai ƙarfi na nau'in haɓaka nau'in da ya dace musamman ga tsofaffi da masu rauni.
***
